Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr;17(2):210-8.
doi: 10.1111/j.1750-3639.2007.00064.x.

The immunopathology of multiple sclerosis: an overview

Affiliations
Review

The immunopathology of multiple sclerosis: an overview

Hans Lassmann et al. Brain Pathol. 2007 Apr.

Abstract

Multiple sclerosis (MS) is traditionally seen as an inflammatory demyelinating disease, characterized by the formation of focal demyelinated plaques in the white matter of the central nervous system. In this review we describe recent evidence that the spectrum of MS pathology is much broader. This includes demyelination in the cortex and deep gray matter nuclei, as well as diffuse injury of the normal-appearing white matter. The mechanisms responsible for the formation of focal lesions in different patients and in different stages of the disease as well as those involved in the induction of diffuse brain damage are complex and heterogeneous. This heterogeneity is reflected by different clinical manifestations of the disease, such as relapsing or progressive MS, and also explains at least in part the relation of MS to other inflammatory demyelinating diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multiple sclerosis pathology: from focal plaques to diffuse brain damage. A. Acute multiple sclerosis (MS) (Pattern II); multiple perivenous inflammatory demyelinating lesions, which form in some places confluent demyelinated plaques. B. Acute MS (Pattern III); focal large demyelinated plaques (green lesions), the right periventricular lesions shows concentric layering. C,D. Benign MS; inactive demyelinated lesions in the spinal cord (D); very few and tiny lesions in the brain white matter and cortex. E. Relapsing/remitting MS; multiple white matter lesions; most of the lesions are remyelinated shadow plaques; the few demyelinated lesions are active; very few and small lesions in the cerebral cortex. F. Secondary progressive MS; multiple large white matter plaques; most plaques are demyelinated, only few are remyelinated; extensive cortical demyelination and multiple lesions in the deep gray matter. G. Primary progressive MS; multiple small focal white matter lesions, most of them remyelinated; extreme cortical demyelination; in addition there is extensive diffuse injury in the normal‐appearing white matter (see figures I–M). H. Secondary progressive MS, large focal demyelinated white matter lesions are associated with extreme cortical demyelination and diffuse white matter atrophy; several lesions are also present in the deep gray matter. I–M. Same patient as shown in figure G; massive injury of the normal‐appearing white matter, consisting of inflammation (CD8 positive lymphocytes are shown in figure I); massive microglia activation with the formation of microglia nodules (shown by staining for HLA‐D in figure J,K) and expression of inducible nitric oxide synthase (shown in figure L); this inflammatory process is associated with extensive axonal injury (staining for neurofilament in figure M). N–O. Secondary progressive MS with massive inflammation in the meninges, composed of T cells (CD8+; figure N) and plasma cells (staining for immunoglobulin; figure O). Green: demyelinated lesions in the white matter; blue: remyelinated lesions in the white matter; red: demyelinated lesions in the cortex; pink: demyelinated lesions in the deep gray matter.

Comment in

  • Addendum.
    Lassmann H. Lassmann H. Brain Pathol. 2007 Jul;17(3):325. doi: 10.1111/j.1750-3639.2007.00078.x. Brain Pathol. 2007. PMID: 17598826 Free PMC article. No abstract available.

References

    1. Aboul‐Enein F, Rauschka H, Kornel B, Stadelmann C, Stefferl A, Brück W, Lucchinetti CF, Schmidbauer M, Jellinger K, Lassmann H (2003) Preferential loss of myelin associated glycoprotein reflects hypoxia‐like white matter damage in stroke and inflammatory brain diseases. J Neuropath Exp Neurol 62:25–33. - PubMed
    1. Adams RD, Kubik CS (1952) The morbid anatomy of the demyelinating diseases. Am J Med 12:510–546. - PubMed
    1. Allen IV, McKeown SR (1979) A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41:81–91. - PubMed
    1. Allen IV, McQuid S, Miradkhur M, Nevin G (2001) Pathological abnormalities in the normal‐appearing white matter in multiple sclerosis. Neurol Sci 22:141–144. - PubMed
    1. Aloisi F, Pujol‐Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205–217. - PubMed

Publication types